| Year |
Citation |
Score |
| 2024 |
Quave CB, Vasquez AM, Aquino-Miranda G, Bora EP, Chidomere CL, Zhang XO, Engelke DS, Do-Monte FH. Neural signatures of opioid-induced risk-taking behavior in the prelimbic prefrontal cortex. Biorxiv : the Preprint Server For Biology. PMID 38370807 DOI: 10.1101/2024.02.05.578828 |
0.446 |
|
| 2023 |
Zhang XO, Zhang Y, Cho CE, Engelke DS, Smolen P, Byrne JH, Do-Monte FH. Enhancing Associative Learning in Rats With a Computationally Designed Training Protocol. Biological Psychiatry Global Open Science. 4: 165-181. PMID 38298784 DOI: 10.1016/j.bpsgos.2023.07.006 |
0.621 |
|
| 2022 |
Zhang XO, Do Monte FH. Positioning the brainstem within the neural network of threat prediction. Trends in Neurosciences. PMID 36470706 DOI: 10.1016/j.tins.2022.11.004 |
0.632 |
|
| 2019 |
Solomon SR, Solh M, Jackson KC, Zhang X, Kent Holland H, Bashey A, Morris LE. Real-world outcomes of unselected elderly acute myeloid leukemia patients referred to a leukemia/hematopoietic cell transplant program. Bone Marrow Transplantation. PMID 31527818 DOI: 10.1038/S41409-019-0675-1 |
0.304 |
|
| 2019 |
Meybodi MA, Cao W, Luznik L, Bashey A, Zhang X, Romee R, Saber W, Hamadani M, Weisdorf DJ, Chu H, Rashidi A. HLA-haploidentical vs matched-sibling hematopoietic cell transplantation: a systematic review and meta-analysis. Blood Advances. 3: 2581-2585. PMID 31484635 DOI: 10.1182/Bloodadvances.2019000614 |
0.315 |
|
| 2019 |
Solomon SR, Solh M, Zhang X, Morris LE, Holland HK, Bashey A. Fludarabine and Total Body Irradiation Conditioning Prior to Ablative Haploidentical Transplantation: Long-term Safety and Efficacy. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 31247313 DOI: 10.1016/J.Bbmt.2019.06.017 |
0.327 |
|
| 2019 |
Karam E, Laporte J, Solomon SR, Morris LE, Zhang X, Holland HK, Bashey A, Solh MM. Who is a Better Donor for Recipients of Allogeneic Hematopoietic Cell Transplantation: A Young HLA-Mismatched Haploidenitcal Relative or an Older Fully HLA-Matched Sibling or Unrelated Donor? Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 31173900 DOI: 10.1016/J.Bbmt.2019.05.031 |
0.307 |
|
| 2019 |
Solh MM, Dickhaus E, Solomon SR, Morris LE, Zhang X, Holland HK, Bashey A. Fevers post infusion of T-cell replete hla mismatched haploidentical hematopoietic stem cells with post-transplant cyclophosphamide: risk factors and impact on transplant outcomes. Bone Marrow Transplantation. PMID 30953027 DOI: 10.1038/S41409-019-0522-4 |
0.308 |
|
| 2019 |
Karam E, LaPorte J, Sizemore C, Zhang X, Holland HK, Solh M, Morris LE, Bashey A, Solomon SR. Real World Outcomes of Letermovir Prophylaxis in Unselected High Risk CMV Seropositive Hematopoietic Stem Cell Transplant Recipients Blood. 134: 3269-3269. DOI: 10.1182/Blood-2019-131365 |
0.304 |
|
| 2018 |
Solh MM, Solomon SR, Morris LE, Zhang X, Holland HK, Bashey A. The Dilemma of Conditioning Intensity: When Does Myeloablative Conditioning Improve Outcomes for Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 30244109 DOI: 10.1016/J.Bbmt.2018.09.012 |
0.322 |
|
| 2018 |
Bashey ZA, Zhang X, Brown S, Jackson K, Morris LE, Holland HK, Bashey A, Solomon SR, Solh M. Comparison of outcomes following transplantation with T-replete HLA-haploidentical donors using post-transplant cyclophosphamide to matched related and unrelated donors for patients with AML and MDS aged 60 years or older. Bone Marrow Transplantation. PMID 29523888 DOI: 10.1038/S41409-018-0126-4 |
0.311 |
|
| 2018 |
Solomon SR, Zhang X, Holland HK, Morris LE, Solh M, Bashey A. Superior Survival of Black Versus White Patients Following Post-Transplant Cyclophosphamide-Based Haploidentical Transplantation for Adults with Hematologic Malignancy. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 29378303 DOI: 10.1016/J.Bbmt.2018.01.024 |
0.3 |
|
| 2018 |
Solh MM, Bashey A, Solomon SR, Morris LE, Zhang X, Brown S, Holland HK. Long term survival among patients who are disease free at 1-year post allogeneic hematopoietic cell transplantation: a single center analysis of 389 consecutive patients. Bone Marrow Transplantation. PMID 29335633 DOI: 10.1038/S41409-017-0076-2 |
0.34 |
|
| 2018 |
Solh M, Zhang X, Bashey A, Morris LE, Bashey Z, Holland HK, Solomon SR. Transplant Rates and Outcomes of Young Acute Myeloid Leukemia (AML) Patients with Intermediate and Poor Risk Disease Referred to a Coordinated Acute Leukemia and Hematopoietic Stem Cell Transplant (HSCT) Program Blood. 132: 4797-4797. DOI: 10.1182/Blood-2018-99-119185 |
0.309 |
|
| 2018 |
Solh M, Solomon SR, Morris LE, Holland HK, Zhang X, Bashey A. The Choice of Induction Regimen Affects Post Remission Survival of Acute Myelogenous Leukemia (AML) Patients with Intermediate or Poor Risk Disease Blood. 132: 82-82. DOI: 10.1182/Blood-2018-99-118789 |
0.328 |
|
| 2018 |
Solomon SR, Zhang X, Solh M, Morris LE, Holland HK, Bashey A. Long-Term Follow-up of Myeloablative Haploidentical (HID) Peripheral Blood Stem Cell Transplantation and Post-Transplant Cyclophosphamide (PTCy) Following Fludarabine and Total Body Irradiation (TBI) Blood. 132: 3368-3368. DOI: 10.1182/Blood-2018-99-111029 |
0.319 |
|
| 2017 |
Baron J, Ridgeway M, Zhang X, Bashey A, Solomon SR, Holland HK, Morris LE, Solh MM. Identifying Risk Factors for Acute and Chronic Graft-Versus-Host Disease in T-Replete HLA-Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide Blood. 130: 1977-1977. DOI: 10.1182/Blood.V130.Suppl_1.1977.1977 |
0.304 |
|
| Show low-probability matches. |